# US 2023/0416691 A1 · Methods relating to intestinal organ-on-a-chip

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0416691 A1
- Document ID: US20230416691A1
- Status: Published application
- Kind: A1
- Application number: 18/242,731
- Filed: 2023-09-06
- Published: 2023-12-28
- Earliest claimed: 2016-09-13
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: Donald E. INGBER; Magdalena KASENDRA; Alexandra SONTHEIMER-PHELPS; Alessio TOVAGLIERI
- Web page: https://patentgrep.com/patent/US20230416691A1

## CPC

- C12N 5/0697: {Artificial constructs associating cells of different lineages, e.g. tissue equivalents (blood vessels C12N5/0691)}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- C12N 5/0062: {General methods for three-dimensional culture}
- C12N 5/0068: {General culture methods using substrates (for specific animal cell type C12N5/06)}
- C12N 5/0679: {Cells of the gastro-intestinal tract}
- G01N 33/5088: {of vertebrates}
- C12N 2501/11: Epidermal growth factor [EGF]
- C12N 2501/345: Gastrin; Cholecystokinins [CCK]
- C12N 2501/415: Wnt; Frizzeled
- C12N 2502/1323: Adult fibroblasts
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Described herein are methods for providing an in vitro intestinal model system, e.g., using primary cells instead of cell lines and/or cancerous cells.

## Claims

### Claim 1

A method comprising:
a) providing
i) adult intestinal stem cells, and
ii) a microfluidic culture device, the device comprising a porous membrane having a first surface and a second surface, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid;
b) introducing said adult intestinal stem cells into said microchannel on said first surface of said porous membrane; and
c) culturing said adult intestinal stem cells under fluid flow conditions.

### Claim 2 (depends on 1)

The method of claim 1, wherein said adult intestinal stem cells are in a mixture comprising other cells.

### Claim 3 (depends on 1)

The method of claim 1, wherein said adult intestinal stem cells are part of an intestinal epithelial monolayer derived from enteroid fragments.

### Claim 4 (depends on 1)

The method of claim 1, wherein said adult intestinal stem cells express Lgr5.

### Claim 5 (depends on 1)

The method of claim 1, wherein said adult intestinal stem cells are cultured in the presence of Wnt-3A.

### Claim 6 (depends on 5)

The method of claim 5, wherein said adult intestinal stem cells are thereafter cultured in the absence of Wnt-3A.

### Claim 7 (depends on 6)

The method of claim 6, further comprising detecting differentiated intestinal cell types.

### Claim 8 (depends on 1)

The method of claim 1, further comprising introducing endothelial cells on said second surface of said membrane and culturing said endothelial cells under fluid flow conditions.

### Claim 9

A method comprising:
a) providing
i) enteroid- or colonoid-derived intestinal epithelial cells,
ii) intestinal endothelial cells, and
iii) a microfluidic culture device, the device comprising a porous membrane having a first surface and a second surface, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid;
b) seeding said first surface with said intestinal epithelial cells so as to create seeded intestinal epithelial cells and seeding said second surface with said intestinal endothelial cells so as to create seeded endothelial cells;
c) expanding said seeded intestinal epithelial cells in a first media comprising Wnt-3A so as to create a monolayer of the intestinal epithelial cells;
d) replacing said first media comprising Wnt-3A and culturing said epithelial cells with a second media lacking Wnt-3A; and
e) culturing said intestinal endothelial cells in a third media comprising Wnt-3A.

### Claim 10 (depends on 9)

The method of claim 9, wherein said first media further comprises Noggin.

### Claim 11 (depends on 9)

The method of claim 9, wherein said first media further comprises a ROCK inhibitor.

### Claim 12 (depends on 9)

The method of claim 9, wherein said first media further comprises R-spondin.

### Claim 13

A method of providing an in vitro intestinal model system, the method comprising:
a) providing
i) intestinal endothelial cells,
ii) an intestinal enteroid or colonoid comprising primary intestinal epithelial cells,
iii) a microfluidic culture device, the device comprising a porous membrane having a first surface and a second surface, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid;
b) disrupting said intestinal enteroid or colonoid comprising primary intestinal epithelial cells into enteroid or colonoid fragments;
c) seeding said first surface of said porous membrane with said enteroid or colonoid fragments so as to create seeded primary intestinal epithelial cells;
d) seeding said second surface of said porous membrane with said intestinal endothelial cells;
e) expanding said seeded primary intestinal epithelial cells in a first media comprising Wnt-3A so as to create a monolayer of the intestinal epithelial cells;
f) replacing said first media comprising Wnt-3A and culturing said epithelial cells with a second media lacking Wnt-3A; and
g) culturing said intestinal endothelial cells in a third media comprising Wnt-3A.

### Claim 14 (depends on 13)

The method of claim 13, wherein said first media further comprises Noggin.

### Claim 15 (depends on 13)

The method of claim 13, wherein said first media further comprises a ROCK inhibitor.

### Claim 16 (depends on 13)

The method of claim 13, wherein said first media further comprises R-spondin.

### Claim 17

A microfluidic culture device comprising a porous membrane having a first surface and a second surface, said membrane in fluidic communication with a microchannel, said microchannel in fluidic communication with a source of fluid, wherein living adult intestinal stem cells are positioned on said first surface of said membrane, said cells expressing Lgr5.

### Claim 18 (depends on 17)

The device of claim 17, wherein said adult intestinal stem cells are in a mixture comprising other cells.

### Claim 19 (depends on 17)

The device of claim 17, wherein said adult intestinal stem cells are part of an intestinal epithelial monolayer derived from enteroid fragments.
